Fuchs Charles S.
Insider CIK 1719576 · CTMX Director · ERAS President, R&D
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ERAS Erasca, Inc. | A Award deriv | 2026-08-10 | 2026-08-12 | 1,300,000 | — | $0 | 1,300,000 | SEC↗ |
| ERAS Erasca, Inc. | A Award deriv | 2026-08-10 | 2026-08-12 | 1,300,000 | — | $0 | 1,300,000 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2026-07-24 | 2026-07-30 | 118,000 | — | $0 | 118,000 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2026-07-24 | 2026-07-30 | 118,000 | — | $0 | 118,000 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2020-06-17 | 2020-06-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2019-06-19 | 2019-06-21 | 14,000 | — | $0 | 14,000 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2018-06-13 | 2018-06-15 | 14,000 | — | $0 | 14,000 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2017-10-23 | 2017-10-24 | 28,000 | — | $0 | 28,000 | SEC↗ |